Change of Adviser & Rule 17 Schedule Two(g) Update

Revolution Beauty Group PLC
08 December 2023
 

8 December 2023

 

Revolution Beauty Group plc

("Revolution Beauty", the "Group" or the "Company")

 

Change of Adviser and AIM Rule 17 Schedule Two(g) Update

 

Revolution Beauty Group plc (AIM: REVB), the multi-channel mass beauty innovator, is pleased to announce the appointment of Liberum Capital Limited ("Liberum") as nominated adviser and joint corporate broker with immediate effect. Liberum were previously engaged as the Company's joint corporate broker. Zeus will remain as joint corporate broker.

 

For further information please contact:

 

Investor Relations

Lauren Brindley, CEO

Elizabeth Lake, CFO

Investor.Relations@revolutionbeautyplc.com

 

Joint Corporate Brokers

Liberum (NOMAD): Edward Thomas / Dru Danford / John More

Tel: +44 (0) 203 100 2222

 

Zeus: Nick Cowles / Jamie Peel / Ben Robertson

Tel: +44 (0) 161 831 1512

 

Media enquiries

Headland Consultancy: Matt Denham / Will Smith / Antonia Pollock

Tel: +44 (0)20 3805 4822

Revolutionbeauty@headlandconsultancy.com

 

 

Existing Board - AIM Rule 17 Disclosures

 

Revolution Beauty also announces the following information relating to directors' disclosure under Schedule Two, paragraph (g) of the AIM Rules for Companies as an update to the information provided in the announcement published on 31 August 2023 regarding the appointment of Colin Henry as Independent Non-Executive Director.

 

Colin was a director of CV Financial Services Limited until 24 May 2016 which went into creditors voluntary liquidation on 8 December 2014 and was dissolved on 24 May 2016. There were no third party creditors and none came to light during the process of liquidation.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings